Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 018680/0524 | |
| Pages: | 8 |
| | Recorded: | 12/27/2006 | | |
| Attorney Dkt #: | 09857/0203379-US0 |
| Conveyance: | DIVISION OF COMPANY |
|
|
Total properties:
5
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10518159
|
Filing Dt:
|
01/18/2005
|
|
Publication #:
|
|
Pub Dt:
|
04/20/2006
| | | | |
|
Title:
|
Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10560179
|
Filing Dt:
|
12/09/2005
|
|
Publication #:
|
|
Pub Dt:
|
01/25/2007
| | | | |
|
Title:
|
Neurocyte protective agent
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2011
|
Application #:
|
10595858
|
Filing Dt:
|
07/11/2006
|
|
Publication #:
|
|
Pub Dt:
|
12/28/2006
| | | | |
|
Title:
|
HERG CHANNEL-EXPRESSING CELL
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11111504
|
Filing Dt:
|
04/20/2005
|
|
Publication #:
|
|
Pub Dt:
|
10/26/2006
| | | | |
|
Title:
|
Therapeutic agent for Abeta related disorders
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/08/2014
|
Application #:
|
11226655
|
Filing Dt:
|
09/13/2005
|
|
Publication #:
|
|
Pub Dt:
|
06/22/2006
| | | | |
|
Title:
|
USE OF SULFONAMIDE-INCLUDING COMPOUNDS IN COMBINATION WITH ANGIOGENESIS INHIBITORS
|
|
|
Assignee
|
|
|
|
|
| 6-10 KOISHIKAWA 4-CHOME, BUNKYO-KU |
| TOKYO, JAPAN 112-8088 |
|
|
Correspondence name and address
|
| |
JOSEPH R. ROBINSON
|
| |
P.O. BOX 5257
|
| |
NEW YORK, NY 10150-5257
|
Search Results as of:
05/03/2024 03:19 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
